NIH-funded research R21 grant

Investigating how mutations in the CACNA1A gene affect brain function and coordination.

Official title: Assessing Synaptic and Intrinsic Effects of Patient-Derived ID-Associated CACNA1A Mutations Using Multiple Models

Funded at Albert Einstein College of Medicine · NIH-10819562 · Data updated 2026-11-12

This study is looking at how certain changes in a gene related to conditions like Episodic Ataxia type 2 and Familial Hemiplegic Migraine affect brain function, and it aims to help people with these symptoms understand their condition better and find better treatments.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startMay 1, 2023
Project endDecember 31, 2025
Funding year2024
Award (this year)$210,000
NIH project number5R21NS132111-02
Project IDNIH-10819562 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Episodic Ataxia type 2, Familial Hemiplegic Migraine, or those exhibiting cognitive dysfunction linked to CACNA1A mutations.

Less likely to help

Patients without CACNA1A mutations or those with unrelated neurological disorders may not benefit from this research.

What this research studies

This research focuses on understanding the effects of specific mutations in the CACNA1A gene, which is linked to neurological disorders like Episodic Ataxia type 2 and Familial Hemiplegic Migraine. By using various models, the study aims to explore how these mutations impact neuronal excitability and cognitive functions. Patients with overlapping symptoms of these disorders may benefit from insights gained about their condition. The research will involve analyzing the functional consequences of different mutations to better classify and treat affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnosis and targeted treatments for patients with CACNA1A-related disorders.

How similar studies have gone: Previous research has shown promising results in understanding the role of CACNA1A mutations in neurological disorders, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Kurshan, Peri T — Albert Einstein College of Medicine
  • Study coordinator: Kurshan, Peri T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.